Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's overall...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tregitopes derived from canine proteins can enhance T regulatory lymphocytes frequency in dog peripheral blood mononuclear cells (PBMC) culture in vitro.

Journal of leukocyte biology·2025

Same author

Distribution, lipophilicity and tissue half-life as key factors in sulphonamide clearance from porcine tissues.

Journal of veterinary research·2025

Same author

Pharmacokinetic Interaction Between Olaparib and Regorafenib in an Animal Model.

Pharmaceutics·2025

Same author

A Pharmacokinetic Study of the Interaction Between Regorafenib and Paracetamol in Male Rats.

Pharmaceutics·2024

Same author

Assessment of omeprazole and famotidine effects on the pharmacokinetics of tacrolimus in patients following kidney transplant-randomized controlled trial.

Frontiers in pharmacology·2024

Same author

Bidirectional pharmacokinetic drug interactions between olaparib and metformin.

Cancer chemotherapy and pharmacology·2023

Search research articles

Related Experiment Video

Updated: May 10, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Method of variability optimization in pharmacokinetic data analysis.

Tomasz Grabowski¹, Jerzy Jan Jaroszewski, Walerian Piotrowski

¹Polpharma Biologics, Trzy lipy 3, 80-172, Gdańsk, Poland, tomasz.grabowski@polpharma.com.

European Journal of Drug Metabolism and Pharmacokinetics

|June 20, 2013

Summary

This study introduces a novel data transformation method to reduce variability in drug concentration-time data for oral medications. This optimization enhances pharmacokinetic analysis precision, particularly for itraconazole.

More Related Videos

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Related Experiment Videos

Last Updated: May 10, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

A Workflow for Lipid Nanoparticle (LNP) Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models (SVEM)

Published on: August 18, 2023

Area of Science:

Pharmacokinetics
Drug Metabolism and Pharmacokinetics
Analytical Chemistry

Background:

High variability in oral drug concentration-time (C-T) data complicates pharmacokinetic analysis, especially during absorption and distribution phases.
Accurate pharmacokinetic profiling is crucial for effective drug therapy and understanding drug behavior in vivo.

Purpose of the Study:

To develop and validate a data transformation method for C-T values to significantly reduce standard deviation (SD) without altering mean concentrations.
To improve the precision of pharmacokinetic parameter estimation for orally administered drugs.

Main Methods:

Optimization of arithmetic mean, geometric mean, and median using the lowest relative standard deviation from the elimination phase and analytical method precision.
Application of the transformation method to C-T data from single oral itraconazole administration in human subjects.
Non-compartmental modeling was employed to estimate key pharmacokinetic parameters.

Main Results:

The optimized data transformation method resulted in a more than twofold reduction in the standard deviation of pharmacokinetic parameters.
Transformed itraconazole data exhibited reduced concentration variability, leading to a more selective pharmacokinetic profile in the absorption and early distribution phases.
The method demonstrated statistical significance in reducing SD while maintaining the integrity of mean concentration values.

Conclusions:

The proposed data transformation technique effectively reduces variability in oral drug C-T data, enhancing pharmacokinetic analysis.
This method offers a valuable tool for improving the accuracy and reliability of pharmacokinetic studies, particularly for drugs with high inter-individual variability.
The enhanced precision in pharmacokinetic profiles aids in better understanding drug absorption and distribution dynamics.